Project Grant R35GM161784
- Federal Project Grant Award Summary The Ohio State University received a $410,893 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026 through December 31, 2030. This award supports fundamental research in genomics-accelerated discovery and biosynthesis of phosphonic acid natural products (NPs). The research aims to discover novel microbial natural products with...
- Federal Project Grant Award Summary The Ohio State University received a $303,082 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded April 1, 2026, with completion scheduled for January 31, 2030. This award funds fundamental biomedical research investigating mast-cell-specific MRGPRB2 signaling pathways in wound healing and scar formation. The research seeks to elucidate mechanisms...
- Federal Project Grant Award Summary The Ohio State University received a $416,726 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 11, 2025, with completion targeted for August 31, 2030. The project focuses on developing mass spectrometry-based technologies to enable chemical analysis of organoids—three-dimensional cell cultures derived from human or animal tissues—with...
- Federal Project Grant Award Summary The Ohio State University received a $2,130,924 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2029. This award supports fundamental research into developmental regulation of oscillatory gene expression, specifically investigating the segmentation clock mechanism that controls somitogenesis—the...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded The Ohio State University a $787,500 Project Grant effective August 15, 2025, through July 31, 2027, under the Aging Research program (CFDA 93.866). This research project investigates the effect of age-related changes in macrophage polarization and post-injury immune response on fracture healing in elderly patients. The primary deliverable is scientific research quantifying differences in fracture microenvironments between...
- Federal Grant Award Summary The Ohio State University Office of Sponsored Programs received a $249,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on August 22, 2025, with a completion date of July 31, 2028. This grant funds fundamental research investigating the role of RNase L (ribonuclease L) host messenger RNA (mRNA) cleavage in viral infections, specifically examining how...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Ohio State University a $419,674 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to conduct fundamental research on gene regulation by small noncoding ribonucleic acids (RNAs). The award, effective May 1, 2026 through January 31, 2031, supports structural and functional studies of human argonaute (AGO) proteins and tiny guide RNAs (tinyRNAs or tyRNAs)—guide...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Ohio State University a Project Grant of $375,898 on March 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct a five-year research initiative investigating oligosaccharide cross-feeding and competition in microbial communities. The research will characterize how human gut bacteria structurally modify oligosaccharide intermediates produced during dietary...
- Federal Project Grant Award Summary The University of Michigan received a $409,941 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 5, 2026, with completion targeted for December 31, 2030. The award supports a research program focused on developing translational treatments for chronic wound healing through cellular reprogramming strategies. The research centers on four...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Ohio State University a Project Grant of $354,416 under the Allergy and Infectious Diseases Research program (CFDA 93.855) beginning February 2, 2026, with completion targeted for January 31, 2028. The research will be conducted at the university's Columbus, Ohio location under the Office of Sponsored Programs Division. This grant supports investigator-initiated biomedical research...
The Ohio State University received a $433,125 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), with an award date of June 1, 2026 and completion date of January 31, 2031. The research project, titled "Understanding Metabolic Reprogramming in Reparative Macrophages," focuses on investigating the molecular mechanisms by which metabolic changes in macrophages—specifically involving phosphoserine aminotransferase 1 (PSAT1) and serine synthesis pathways—influence epigenetic modifications that regulate macrophage anti-inflammatory function in wound healing and tissue repair. The project addresses a significant public health challenge, as chronic or non-healing wounds affect over 2.5 percent of the U.S. population. The research will elucidate the relationship between metabolic reprogramming and epigenetic regulation in macrophages, examining how PSAT1-mediated serine synthesis affects mitochondrial heme synthesis, respiratory activity, and histone demethylation—processes critical to macrophage differentiation and reparative function. Findings from this fundamental biomedical research are expected to establish a scientific foundation for potential advances in treating chronic wounds and related tissue repair complications.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $433.1k | 6/1/26 |